$117.67
-0.08 (-0.07%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+130.68%
YTD
+61.72%
Open$117.75
Previous Close$117.75
Day High$119.53
Day Low$116.61
52W High$130.05
52W Low$47.86
Volume—
Avg Volume630.4K
Market Cap9.85B
P/E Ratio—
EPS$-3.24
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.66
Above
SMA 200
$56.03
Above
RSI (14)
77.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
30 analysts
Price Target
-73.6% upside
Current
$117.67
$117.67
Target
$31.03
$31.03
$20.33
$31.03 avg
$33.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.83M | 41.20M | 7.83B |
| Net Income | -308,309,663 | -294,407,105 | 335.40M |
| Profit Margin | -794.0% | -754.3% | 4.3% |
| EBITDA | -337,760,139 | -340,447,885 | 592.59M |
| Free Cash Flow | — | — | 369.62M |
| Rev Growth | -5.8% | -5.8% | +18.7% |
| Debt/Equity | 0.00 | 0.00 | 0.53 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.73 | +0.29% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $392.34 | +1.73% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.59 | +0.99% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $511.29 | +0.58% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $794.14 | +1.18% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.64 | +2.12% | 40.0 | 32.33B |